Posticy
Boost your SEO with Backlinks that are worth it
SR Ranko
Turn scattered startup information into focused action.
SR Booster
Submit your startup to 120+ top directories.
  • Last Ranking Update: 9 hours ago
  • Company

Company Rank

47,948

Country Rank

SR Score

639

SR Web

600

SR Social

1,385

Kolltan Pharmaceuticals develops new-generation monoclonal antibody oncology therapeutics.

Acquired by Celldex Therapeutics on November 01, 2016

Website: https://www.kolltan.com

Founded: January 01, 2007

 SR Traffic - Month

 Ahrefs

X

Kolltan Pharmaceuticals Competitors

Add Competitor

Startup Industry Description
24Genetics
Pharmaceuticals & Biotechnology DNA Testing for Ancestry and wellness - 24Genetics is a European Biotechnology startup tha ...
Vivodyne
Healthcare Equipment & Services Discovers life-changing drugs and cellular therapies - Vivodyne accelerates the discovery of cures to hum ...
Turn Biotechnologies
Pharmaceuticals & Biotechnology Fighting age-related disease at the cellular level - Turn Biotechnologies, Inc. is a Silicon Valley-bas ...
View more competitors»

Kolltan Pharmaceuticals Funding

Add Funding

Date Round Amount Investors
Mar 19, 2014 Series D $ 60,000,000
Mar 08, 2012 Series C $ 25,000,000
Sep 16, 2010 Venture $ 6,000,000
View more funding rounds»

Kolltan Pharmaceuticals Acquisitions

Add Acquisition

Date Acquired Amount
There are no acquisitions.

Kolltan Pharmaceuticals Products

Add Product

Product Stage Description
There are no products.

Kolltan Pharmaceuticals Team

Add Team Member

Person Role Period
Joseph Schlessinger
Founder Unknown to Unknown
Arthur Altschul Jr.
Founder Unknown to Unknown

Kolltan Pharmaceuticals News

Add News

Date Title
There are no news.

Kolltan Pharmaceuticals Statistics

Last Week

Rank

SR Score

Likes

Followers



Last Month

Rank

SR Score

Likes

Followers